false
English
Catalog
Topic 4: Future Directions & Emerging Technologies
Biomarkers in Lung Cancer Screening (Non Imaging)
Biomarkers in Lung Cancer Screening (Non Imaging)
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The speaker discusses the importance of molecular biomarkers in lung cancer screening, highlighting that only a quarter of lung cancers in the U.S. are diagnosed early despite ongoing screenings. Challenges include low uptake, adherence, and the balance of screening benefits versus harms. Biomarkers undergo several developmental phases: discovery, analytical validation, clinical validation, and clinical utility, each with specific aims. Examples of ongoing studies show promising biomarkers that may enhance current lung cancer screening methods. Multi-cancer early detection tests could potentially contribute, but more development is needed for significant impact.
Asset Subtitle
Peter Mazzone
Keywords
molecular biomarkers
lung cancer screening
early detection
clinical validation
multi-cancer tests
×
Please select your language
1
English
5
普通话
11
Dutch